Anaveon, a late-stage Swiss pre-clinical biotech focused on reprogramming the immune system with precision biologics, today ...
Anaveon, a late-stage preclinical biotech focused on reprogramming the immune system with precision biologics, announces ...
Transition from milk to solid food reshapes gut microbes, triggering epigenetic changes in intestinal stem cells that create lasting immune memory, strengthening responses, and reducing disease risk ...
As cell therapy advances toward clinical reality, iPSC-derived cellular products, in vivo reprogramming strategies, and ...
SAN FRANCISCO, 22nd March, 2026 (WAM) -- Scientists at the University of California have developed a new method to treat blood cancers by reprogramming immune cells directly inside the patient’s body, ...
Researchers at UC San Francisco have now developed a way to reprogram these cancer-fighting cells directly inside the body. This new method could remove the need for external manufacturing, ...
A breakthrough in CAR-T therapy may allow cancer treatment with a single injection, cutting costs and making care more available.
Digestive tract tumors are malignant diseases characterized by high aggressiveness, heterogeneity and metabolic abnormalities ...
The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...
Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the ...
According to a team of researchers at Baylor College of Medicine, Tongji University and collaborating institutions, weaning ...